EP4178548
LYFJASAMSETNINGAR SEM SAMANSTANDA AF (S)-4-(4-(4-(((2-(2,6-DÍOXÓPÍPERIDÍN-3-ÝL)-1-OXÓÍSÓINDÓLÍN-4- ÝL)OXÝ)M ETÝL)BENSÝL)PÍPERASÍN-1-ÝL)-3-FLÚORÓBENSÓNÍTRÍL OG AÐFERÐIR TIL NOTKUNAR ÞEIRRA
:
EP einkaleyfi í gildi á Íslandi:
6.7.2021:
24.7.2024:
21755119.1
:
29.8.2024:
15.10.2024
:
5.7.2041:
5.7.2026:
31.7.2026
:
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)M ETHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAME
6.7.2021
24.7.2024
29.8.2024
15.10.2024
5.7.2026
:
Celgene Corporation:
Route 206 & Province Line Road, Princeton, NJ 08543, US
:
AGRAWAL, Anjali:
Summit, NJ 07901, US
:
MITRA, Biplob, K.:
Summit, NJ 07901, US
:
THOOL, Prajwal, Gunwanth:
Summit, NJ 07901, US
:
HIGGINS-GRUBER, Shannon:
Summit, NJ 07901, US
:
RODRIGUEZ, Jennifer, Almodovar:
Summit, NJ 07901, US
:
LIU, Demin:
Summit, NJ 07901, US
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
202063048998 P:
7.7.2020:
US
:
US2021040452:
6.7.2021
:
A61K 9/16, A61K 9/48, A61P 35/00, A61P 1/00, A61K 31/496
: 5
: 4.7.2025
: 5.7.2026
: Árnason Faktor ehf.